These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


910 related items for PubMed ID: 12796377

  • 1. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
    Shiina H, Igawa M, Breault J, Ribeiro-Filho L, Pookot D, Urakami S, Terashima M, Deguchi M, Yamanaka M, Shirai M, Kaneuchi M, Kane CJ, Dahiya R.
    Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377
    [Abstract] [Full Text] [Related]

  • 2. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
    Araki Y, Okamura S, Hussain SP, Nagashima M, He P, Shiseki M, Miura K, Harris CC.
    Cancer Res; 2003 Feb 01; 63(3):728-34. PubMed ID: 12566320
    [Abstract] [Full Text] [Related]

  • 3. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
    Esufali S, Bapat B.
    Oncogene; 2004 Oct 28; 23(50):8260-71. PubMed ID: 15377999
    [Abstract] [Full Text] [Related]

  • 4. Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling.
    Kojima T, Shimazui T, Hinotsu S, Joraku A, Oikawa T, Kawai K, Horie R, Suzuki H, Nagashima R, Yoshikawa K, Michiue T, Asashima M, Akaza H, Uchida K.
    Oncogene; 2009 Jan 15; 28(2):297-305. PubMed ID: 18931698
    [Abstract] [Full Text] [Related]

  • 5. Frequent alterations of the beta-catenin and TCF-4 genes, but not of the APC gene, in colon cancers with high-frequency microsatellite instability.
    Fukushima H, Yamamoto H, Itoh F, Horiuchi S, Min Y, Iku S, Imai K.
    J Exp Clin Cancer Res; 2001 Dec 15; 20(4):553-9. PubMed ID: 11876551
    [Abstract] [Full Text] [Related]

  • 6. Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas.
    Schwartz DR, Wu R, Kardia SL, Levin AM, Huang CC, Shedden KA, Kuick R, Misek DE, Hanash SM, Taylor JM, Reed H, Hendrix N, Zhai Y, Fearon ER, Cho KR.
    Cancer Res; 2003 Jun 01; 63(11):2913-22. PubMed ID: 12782598
    [Abstract] [Full Text] [Related]

  • 7. Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402.
    Zhao DH, Hong JJ, Guo SY, Yang RL, Yuan J, Wen CY, Zhou KY, Li CJ.
    Cell Res; 2004 Feb 01; 14(1):74-80. PubMed ID: 15040893
    [Abstract] [Full Text] [Related]

  • 8. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE, Wang MX, Li RQ.
    Cancer Invest; 2009 Jul 01; 27(6):604-12. PubMed ID: 19440933
    [Abstract] [Full Text] [Related]

  • 9. Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations.
    Bilim V, Kawasaki T, Katagiri A, Wakatsuki S, Takahashi K, Tomita Y.
    Clin Cancer Res; 2000 Feb 01; 6(2):460-6. PubMed ID: 10690524
    [Abstract] [Full Text] [Related]

  • 10. The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines.
    Duval A, Rolland S, Tubacher E, Bui H, Thomas G, Hamelin R.
    Cancer Res; 2000 Jul 15; 60(14):3872-9. PubMed ID: 10919662
    [Abstract] [Full Text] [Related]

  • 11. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
    Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y, Nakamura Y.
    Nat Genet; 2000 Mar 15; 24(3):245-50. PubMed ID: 10700176
    [Abstract] [Full Text] [Related]

  • 12. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.
    Murakami T, Toda S, Fujimoto M, Ohtsuki M, Byers HR, Etoh T, Nakagawa H.
    Biochem Biophys Res Commun; 2001 Oct 19; 288(1):8-15. PubMed ID: 11594745
    [Abstract] [Full Text] [Related]

  • 13. Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas.
    Sareddy GR, Panigrahi M, Challa S, Mahadevan A, Babu PP.
    Neurochem Int; 2009 Sep 19; 55(5):307-17. PubMed ID: 19576519
    [Abstract] [Full Text] [Related]

  • 14. Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours.
    Wong SC, Lo SF, Lee KC, Yam JW, Chan JK, Wendy Hsiao WL.
    J Pathol; 2002 Feb 19; 196(2):145-53. PubMed ID: 11793365
    [Abstract] [Full Text] [Related]

  • 15. WNT-1 expression in basal cell carcinoma of head and neck. An immunohistochemical and confocal study with regard to the intracellular distribution of beta-catenin.
    Lo Muzio L, Pannone G, Staibano S, Mignogna MD, Grieco M, Ramires P, Romito AM, De Rosa G, Piattelli A.
    Anticancer Res; 2002 Feb 19; 22(2A):565-76. PubMed ID: 12014624
    [Abstract] [Full Text] [Related]

  • 16. WNT-1 and HGF regulate GSK3 beta activity and beta-catenin signaling in mammary epithelial cells.
    Papkoff J, Aikawa M.
    Biochem Biophys Res Commun; 1998 Jun 29; 247(3):851-8. PubMed ID: 9647782
    [Abstract] [Full Text] [Related]

  • 17. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis.
    Bhatia N, Spiegelman VS.
    Mol Carcinog; 2005 Apr 29; 42(4):213-21. PubMed ID: 15765534
    [Abstract] [Full Text] [Related]

  • 18. Identification of Tcf-4 as a transcriptional target of p53 signalling.
    Rother K, Johne C, Spiesbach K, Haugwitz U, Tschöp K, Wasner M, Klein-Hitpass L, Möröy T, Mössner J, Engeland K.
    Oncogene; 2004 Apr 22; 23(19):3376-84. PubMed ID: 14990988
    [Abstract] [Full Text] [Related]

  • 19. Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling.
    van de Wetering M, Barker N, Harkes IC, van der Heyden M, Dijk NJ, Hollestelle A, Klijn JG, Clevers H, Schutte M.
    Cancer Res; 2001 Jan 01; 61(1):278-84. PubMed ID: 11196175
    [Abstract] [Full Text] [Related]

  • 20. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.
    González-Sancho JM, Aguilera O, García JM, Pendás-Franco N, Peña C, Cal S, García de Herreros A, Bonilla F, Muñoz A.
    Oncogene; 2005 Feb 03; 24(6):1098-103. PubMed ID: 15592505
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 46.